CAPRICOR THERAPEUTICS, INC. (CAPR) Form 8-K Material Events
CAPRICOR THERAPEUTICS, INC. (CAPR) is a publicly traded company on the Nasdaq, categorized under SIC 2834 (Pharmaceutical Preparations). Access real-time SEC filings, 10-K annual reports, 10-Q quarterlies, 8-K current reports, PCAOB auditor history, and executive compensation disclosures.
Ticker: CAPR
CIK: 1133869
Exchange: Nasdaq
SIC 2834: Pharmaceutical Preparations
Fiscal Year End: 12/31
State: DE
Independent PCAOB Auditor
Explore PCAOB Audit Intelligence →
Audit Firm
Rose, Snyder & Jacobs LLP
Auditor SinceSince 12/31/2016 12:00:00 AM
Lead Engagement PartnerEvlina Madathian
Audit LocationEncino, California, United States
Latest SEC EDGAR Filings
Showing 10-K, 10-Q, 8-K, Form 4, and other SEC submissions| Form | Filing Date | Reporting Period | Description | Accession Number | Actions |
|---|---|---|---|---|---|
| SCHEDULE 13G/A | 2026-10-14 | — | SCHEDULE 13G/A Filing | 0001104659-26-115876 | View SEC Doc Filr Page |
| SCHEDULE 13G | 2026-09-14 | — | SCHEDULE 13G Filing | 0001104659-26-107591 | View SEC Doc Filr Page |
| 8-K | 2026-08-24 | 2026-08-24 | 8-K | 0001104659-26-100071 | View SEC Doc Filr Page |
| SCHEDULE 13G | 2026-08-19 | — | SCHEDULE 13G Filing | 0001104659-26-098872 | View SEC Doc Filr Page |
| 10-Q | 2026-08-14 | 2026-06-30 | 10-Q | 0001104659-26-097294 | View SEC Doc Filr Page |
| SCHEDULE 13G/A | 2026-08-14 | — | SCHEDULE 13G/A Filing | 0001214659-26-010417 | View SEC Doc Filr Page |
| 8-K | 2026-08-13 | 2026-08-13 | 8-K | 0001104659-26-095908 | View SEC Doc Filr Page |
| SCHEDULE 13G | 2026-08-07 | — | SCHEDULE 13G Filing | 0000093751-26-000426 | View SEC Doc Filr Page |
| SCHEDULE 13G | 2026-08-03 | — | SCHEDULE 13G Filing | 0001346824-26-000208 | View SEC Doc Filr Page |
| 8-K | 2026-07-30 | 2026-07-29 | 8-K | 0001104659-26-088667 | View SEC Doc Filr Page |
| 8-K | 2026-07-29 | 2026-07-29 | 8-K | 0001104659-26-087891 | View SEC Doc Filr Page |
| 8-K | 2026-07-14 | 2026-07-09 | 8-K | 0001104659-26-083559 | View SEC Doc Filr Page |
| 4 | 2026-06-29 | 2026-06-25 | 4 Filing | 0001593086-26-000012 | View SEC Doc Filr Page |
| 4 | 2026-06-29 | 2026-06-25 | 4 Filing | 0001593087-26-000013 | View SEC Doc Filr Page |
| 8-K | 2026-06-26 | 2026-06-26 | 8-K | 0001104659-26-078327 | View SEC Doc Filr Page |
| 4 | 2026-06-24 | 2026-06-22 | 4 Filing | 0001593086-26-000010 | View SEC Doc Filr Page |
| 4 | 2026-06-24 | 2026-06-22 | 4 Filing | 0001593087-26-000011 | View SEC Doc Filr Page |
| 8-K | 2026-06-08 | 2026-06-04 | 8-K | 0001104659-26-071364 | View SEC Doc Filr Page |
| 4 | 2026-05-28 | 2026-05-26 | 4 Filing | 0002137554-26-000006 | View SEC Doc Filr Page |
| 3 | 2026-05-28 | 2026-05-25 | 3 Filing | 0002137554-26-000005 | View SEC Doc Filr Page |
| 4 | 2026-05-19 | 2026-05-18 | 4 Filing | 0001593087-26-000009 | View SEC Doc Filr Page |
| 144/A | 2026-05-19 | — | 144/A Filing | 0001959173-26-003763 | View SEC Doc Filr Page |
| 144 | 2026-05-19 | — | 144 Filing | 0001959173-26-003757 | View SEC Doc Filr Page |
| 4 | 2026-05-14 | 2026-05-13 | 4 Filing | 0001310715-26-000004 | View SEC Doc Filr Page |
| 10-Q | 2026-05-13 | 2026-03-31 | 10-Q | 0001104659-26-060382 | View SEC Doc Filr Page |